Y. Li

机构：Chengdu Military General Hospital, Shandong Provincial QianFoShan Hospital, Shandong First Medical University · ORCID：0009-0008-6787-5588

发表论文 5 篇 · 总被引 29 次 · h-index 3

代表论文

• Brief Report: Ivonescimab Combined With Etoposide Plus Carboplatin as First-Line Treatment for Extensive-Stage SCLC: Results of a Phase 1b Clinical Trial (2024 · Journal of Thoracic Oncology · 被引 19)
• Comparison of totally laparoscopic and laparoscopic-assisted approach in gastrectomy with D2 lymphadenectomy for advanced gastric cancer after neoadjuvant chemotherapy: a retrospective comparative study (2024 · Annals of Surgical Treatment and Research · 被引 5)
• P33.12 Real-World Prevalence of PD-L1 Expression in Chinese Patients with Advanced or Metastatic NSCLC: Express II Study (2021 · Journal of Thoracic Oncology · 被引 4)
• Patient-Derived Organoids (PDO) As the Potential Model to Predict Treatment Outcome of Rectal Cancer Patients Underwent Neo-Adjuvant Chemoradiotherapy (2019 · International Journal of Radiation Oncology*Biology*Physics · 被引 1)
• P47.04 Neuroendocrine Transformation from EGFR-wild type or TKI-naïve Non-Small Cell Lung Cancer: An Under-Recognized Phenomenon? (2021 · Journal of Thoracic Oncology)